# Paper
[Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102646/)

## Paper Code

## Insights
1. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir are potentially potent drugs against SARS-CoV-2 since they tightly bind to its RdRp (RNA dependent RNA polymerase)


## Methods
#### Steps for Quering ViPR

#### HLA (Human Leukocyte Antigen) Population Allele Analysis
#### Population Coverage Pickle File
#### Data Format

## What I Learned